Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 07 06 2022
revised: 01 07 2022
accepted: 07 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Hypertension is a leading risk factor for cardiovascular disease mortality. African Americans (AAs) have the highest prevalence of hypertension in the United States, and to alleviate the burden of hypertension in this population, better control of blood pressure (BP) is needed. Previous studies have shown considerable interpersonal differences in BP response to antihypertensive treatment, suggesting a genetic component. Utilizing data from 4297 AA participants randomized to chlorthalidone from the Genetics of Hypertension Associated Treatments (GenHAT) study, we aimed to identify variants associated with the efficacy of chlorthalidone. An additional aim was to find variants that contributed to changes in fasting glucose (FG) in these individuals. We performed genome-wide association analyses on the change of systolic and diastolic BP (SBP and DBP) over six months and FG levels over 24 months of treatment. We sought replication in the International Consortia of Pharmacogenomics Studies. We identified eight variants statistically associated with BP response and nine variants associated with FG response. One suggestive

Identifiants

pubmed: 35886043
pii: genes13071260
doi: 10.3390/genes13071260
pmc: PMC9319619
pii:
doi:

Substances chimiques

Glucose IY9XDZ35W2
Chlorthalidone Q0MQD1073Q

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : F31 DK128990
Pays : United States
Organisme : NIDDK NIH HHS
ID : F31DK128990
Pays : United States

Références

Circulation. 2008 Sep 23;118(13):1383-93
pubmed: 18809808
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
J Am Heart Assoc. 2015 Jan 26;4(1):e001521
pubmed: 25622599
Hum Mol Genet. 2011 Jun 1;20(11):2285-95
pubmed: 21422096
Atherosclerosis. 2017 Jul;262:171-178
pubmed: 28522145
Curr Hypertens Rep. 2012 Feb;14(1):46-61
pubmed: 22161147
Am J Med Sci. 2014 Aug;348(2):135-8
pubmed: 24983758
Nature. 2021 Feb;590(7845):290-299
pubmed: 33568819
Curr Hypertens Rep. 2011 Feb;13(1):46-54
pubmed: 21128019
Clin Pharmacol Ther. 2021 Sep;110(3):723-732
pubmed: 34231218
Circ J. 2009 Apr;73(4):732-40
pubmed: 19225208
J Hum Hypertens. 2016 Sep;30(9):549-54
pubmed: 26791477
J Am Heart Assoc. 2018 Mar 9;7(6):
pubmed: 29523524
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1492-503
pubmed: 20335315
Biochem J. 2000 Dec 15;352 Pt 3:601-10
pubmed: 11104663
Circ Cardiovasc Genet. 2009 Aug;2(4):362-70
pubmed: 20031608
Nat Genet. 2015 Nov;47(11):1282-1293
pubmed: 26390057
Cardiovasc Ther. 2011 Feb;29(1):37-45
pubmed: 21129164
Am Heart J. 2009 Mar;157(3):442-9
pubmed: 19249413
Circulation. 2004 Nov 23;110(21):3360-6
pubmed: 15545522
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Bioinformatics. 2021 Mar 17;:
pubmed: 33734315
Am J Hypertens. 2011 Mar;24(3):347-54
pubmed: 21151011
J Thorac Cardiovasc Surg. 2010 Sep;140(3):653-9
pubmed: 20219212
Nat Genet. 2011 Sep 11;43(10):1005-11
pubmed: 21909110
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4275-9
pubmed: 41240
Arch Intern Med. 2006 Nov 13;166(20):2191-201
pubmed: 17101936
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
PLoS One. 2007 Aug 01;2(7):e657
pubmed: 17668045
Clin Pharmacol Ther. 2014 Aug;96(2):175-81
pubmed: 24637943
Clin J Am Soc Nephrol. 2009 Feb;4(2):470-80
pubmed: 19218474
Saudi J Biol Sci. 2018 Mar;25(3):469-473
pubmed: 29692649
Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20
pubmed: 12204014
Sci Rep. 2019 Nov 21;9(1):17323
pubmed: 31754133
Curr Hypertens Rep. 2013 Oct;15(5):514-21
pubmed: 23839110
Biosci Rep. 2018 Jun 21;38(3):
pubmed: 29789399
Circulation. 2018 Oct 23;138(17):e426-e483
pubmed: 30354655
Nat Commun. 2015 Feb 26;6:6241
pubmed: 25716000
BMC Genet. 2017 Dec 08;18(1):105
pubmed: 29221444
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
PLoS Genet. 2009 Jul;5(7):e1000564
pubmed: 19609347
Sci Rep. 2016 Aug 02;6:30811
pubmed: 27480026
J Hypertens. 2015 Jun;33(6):1301-9
pubmed: 25695618
J Immunol. 2015 Jun 15;194(12):5885-94
pubmed: 25964488
J Hypertens. 2010 Oct;28(10):2076-83
pubmed: 20577119
Bioinformatics. 2015 Mar 1;31(5):782-4
pubmed: 25338720
J Biol Chem. 2007 Oct 5;282(40):29211-21
pubmed: 17699517
J Hypertens. 2011 Jan;29(1):70-5
pubmed: 20852445
Science. 1983 May 6;220(4597):568-75
pubmed: 6301011
NCHS Data Brief. 2017 Oct;(289):1-8
pubmed: 29155682
Ann Med. 2012 Jun;44 Suppl 1:S17-22
pubmed: 22713143
BMC Med Genet. 2013 Jul 19;14:75
pubmed: 23870195
Microcirculation. 2002;9(4):243-57
pubmed: 12152102
J Am Soc Nephrol. 2006 Nov;17(11):2992-8
pubmed: 17035610
N Engl J Med. 2021 May 20;384(20):1921-1930
pubmed: 34010531
Pharmacogenomics. 2006 Apr;7(3):271-9
pubmed: 16610939
Kidney Int. 2002 Mar;61(3):1047-55
pubmed: 11849460
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
Hum Hered. 2015;79(1):20-7
pubmed: 25765051
J Clin Hypertens (Greenwich). 2016 Apr;18(4):342-51
pubmed: 26395424
Hypertension. 2007 Mar;49(3):473-80
pubmed: 17210832
Am J Hypertens. 2003 Feb;16(2):148-50
pubmed: 12559683
Biometrics. 2020 Dec;76(4):1262-1272
pubmed: 31883270
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Pharmacogenomics J. 2002;2(5):309-17
pubmed: 12439737
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
JAMA. 2000 Apr 19;283(15):1967-75
pubmed: 10789664
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Am J Hypertens. 2016 Nov 1;29(11):1301-1306
pubmed: 27418245
Pharmacogenet Genomics. 2018 Nov;28(11):251-255
pubmed: 30289819
BMC Med Genomics. 2018 Jun 20;11(1):55
pubmed: 29925376
Hypertension. 2001 Jun;37(6):1410-3
pubmed: 11408386
J Clin Hypertens (Greenwich). 2008 Oct;10(10):751-60
pubmed: 19090876

Auteurs

Nicole D Armstrong (ND)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Vinodh Srinivasasainagendra (V)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Lakshmi Manasa S Chekka (LMS)

Division of Applied Regulatory Sciences, Center for Drug Evaluation and Research, Silver Spring, MD 20903, USA.

Nam H K Nguyen (NHK)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.

Noor A Nahid (NA)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.

Alana C Jones (AC)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Rikki M Tanner (RM)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Bertha A Hidalgo (BA)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Nita A Limdi (NA)

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Steven A Claas (SA)

Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 40506, USA.

Yan Gong (Y)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.

Caitrin W McDonough (CW)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.

Rhonda M Cooper-DeHoff (RM)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.
Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32611, USA.

Julie A Johnson (JA)

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.
Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32611, USA.

Hemant K Tiwari (HK)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Donna K Arnett (DK)

Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 40506, USA.
Deans Office, College of Public Health, University of Kentucky, Lexington, KY 40506, USA.

Marguerite R Irvin (MR)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH